SCHEMBL25563152

SCHEMBL25563152

Cn1c2ccccc2c2ccc(N(c3ccccc3)c3ccc4c(c3)C3(c5ccccc5-c5ccc(N(c6ccccc6)c6ccccc6)cc53)c3ccccc3-4)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.39
KIF11 P52732 1/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPT P10636 4/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PABPC1 P11940 1/20 0.36
PDK2 Q15119 2/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
ATM Q13315 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25563547 0.96 GPR3 (0.36) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563617 0.96 GPR3 (0.36) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563376 0.95 RXRA (0.40) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563043 0.94 KDM4E (0.37) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563317 0.93 RXRA (0.38) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563154 0.93 KDM4E (0.40) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL12560196 0.93 KDM4E (0.40) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563661 0.93 GPR3 (0.39) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563217 0.92 HSD17B10 (0.35) GPR3KIF11KDM4EHPGDALDH1A1
SCHEMBL25563620 0.90 KDM4E (0.38) GPR3KIF11KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180502-A1 LIGHT-EMITTING DEVICE INCLUDING DIAMINE COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE DIAMINE COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180502-A1 LIGHT-EMITTING DEVICE INCLUDING DIAMINE COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE DIAMINE COMPOUND AOC1, DTD1, DDT GPR3 3461/4885KIF11 2609/4885KDM4E 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.